世界の百日咳ワクチン販売市場2021

QYResearchが発行した調査報告書(QYR21JN7833)
◆英語タイトル:Global Pertussis Vaccine Sales Market Report 2021
◆商品コード:QYR21JN7833
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月7日(※2024年版があります。お問い合わせください。)
◆ページ数:133
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の百日咳ワクチン市場について種類別(全細胞ワクチン、無細胞ワクチン)、用途別(子供、大人)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・百日咳ワクチン市場の概要
・世界の主要地域別百日咳ワクチン市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の百日咳ワクチン市場規模2016-2021:種類別(全細胞ワクチン、無細胞ワクチン)
・世界の百日咳ワクチン市場予測2012-2027:種類別(全細胞ワクチン、無細胞ワクチン)
・世界の百日咳ワクチン市場規模2016-2021:用途別(子供、大人)
・世界の百日咳ワクチン市場予測2012-2027:用途別(子供、大人)
・百日咳ワクチンのアメリカ市場規模と予測2016-2021
・百日咳ワクチンのヨーロッパ市場規模と予測2016-2021
・百日咳ワクチンの中国市場規模と予測2016-2021
・百日咳ワクチンの日本市場規模と予測2016-2021
・百日咳ワクチンの東南アジア市場規模と予測2016-2021
・百日咳ワクチンのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Sanofi Pasteur、GSK、Mitsubishi Tanabe Pharma、Wuhan Institute of Biological Products、Walvax Biotechnology、Minhai Biotechnology)
・百日咳ワクチンの製造コスト分析
・販売チャネル、流通業者、顧客
・百日咳ワクチンの市場動向・機会・課題
・調査の結論
【レポートの概要】

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Manufacturers take the combination of direct Marketing channel and distribution sales in the form, Future sales channels both direct selling and distribution needs with the help of online sales platform.

The market channel is essential to every manufacturer and they are paying more and more attention to their channel building. Firstly, suppliers can build strong sales teams to directly manage their own customers. At the same time, more flexible and attractive channel incentives can be created and channel support can be provided in different ways. At the meantime, customers are concerning more on the product quality and services. So, except all of the distributors and direct marketing, they are also consider their logistics and services, making sure that both products and services are better than the competitors.

Market Analysis and Insights: Global Pertussis Vaccine Market
The global Pertussis Vaccine market was valued at US$ 5047.1 in 2020 and will reach US$ 5518.8 million by the end of 2027, growing at a CAGR of 1.5% during 2022-2027.

Global Pertussis Vaccine Scope and Market Size
The global Pertussis Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pertussis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Whole-cell vaccines
Acellular vaccines

Segment by Application
Children
Adults

The Pertussis Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Pertussis Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology

【レポートの目次】

1 Pertussis Vaccine Market Overview
1.1 Pertussis Vaccine Product Scope
1.2 Pertussis Vaccine Segment by Type
1.2.1 Global Pertussis Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Whole-cell vaccines
1.2.3 Acellular vaccines
1.3 Pertussis Vaccine Segment by Application
1.3.1 Global Pertussis Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Children
1.3.3 Adults
1.4 Pertussis Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Pertussis Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Pertussis Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Pertussis Vaccine Price Trends (2016-2027)

2 Pertussis Vaccine Estimates and Forecasts by Region
2.1 Global Pertussis Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Pertussis Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Pertussis Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Pertussis Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Pertussis Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Pertussis Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Pertussis Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Pertussis Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Pertussis Vaccine Estimates and Projections (2016-2027)
2.4.3 China Pertussis Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Pertussis Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Pertussis Vaccine Estimates and Projections (2016-2027)
2.4.6 India Pertussis Vaccine Estimates and Projections (2016-2027)
3 Global Pertussis Vaccine Competition Landscape by Players
3.1 Global Top Pertussis Vaccine Players by Sales (2016-2021)
3.2 Global Top Pertussis Vaccine Players by Revenue (2016-2021)
3.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2020)
3.4 Global Pertussis Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Pertussis Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Pertussis Vaccine Market Size by Type
4.1 Global Pertussis Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Pertussis Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Pertussis Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Pertussis Vaccine Price by Type (2016-2021)
4.2 Global Pertussis Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Pertussis Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Pertussis Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Pertussis Vaccine Price Forecast by Type (2022-2027)
5 Global Pertussis Vaccine Market Size by Application
5.1 Global Pertussis Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Pertussis Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Pertussis Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Pertussis Vaccine Price by Application (2016-2021)
5.2 Global Pertussis Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Pertussis Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Pertussis Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Pertussis Vaccine Price Forecast by Application (2022-2027)

6 North America Pertussis Vaccine Market Facts & Figures
6.1 North America Pertussis Vaccine Sales by Company
6.1.1 North America Pertussis Vaccine Sales by Company (2016-2021)
6.1.2 North America Pertussis Vaccine Revenue by Company (2016-2021)
6.2 North America Pertussis Vaccine Sales Breakdown by Type
6.2.1 North America Pertussis Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Pertussis Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Pertussis Vaccine Sales Breakdown by Application
6.3.1 North America Pertussis Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Pertussis Vaccine Sales Breakdown by Application (2022-2027)

7 Europe Pertussis Vaccine Market Facts & Figures
7.1 Europe Pertussis Vaccine Sales by Company
7.1.1 Europe Pertussis Vaccine Sales by Company (2016-2021)
7.1.2 Europe Pertussis Vaccine Revenue by Company (2016-2021)
7.2 Europe Pertussis Vaccine Sales Breakdown by Type
7.2.1 Europe Pertussis Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Pertussis Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Pertussis Vaccine Sales Breakdown by Application
7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)

8 China Pertussis Vaccine Market Facts & Figures
8.1 China Pertussis Vaccine Sales by Company
8.1.1 China Pertussis Vaccine Sales by Company (2016-2021)
8.1.2 China Pertussis Vaccine Revenue by Company (2016-2021)
8.2 China Pertussis Vaccine Sales Breakdown by Type
8.2.1 China Pertussis Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Pertussis Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Pertussis Vaccine Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Pertussis Vaccine Market Facts & Figures
9.1 Japan Pertussis Vaccine Sales by Company
9.1.1 Japan Pertussis Vaccine Sales by Company (2016-2021)
9.1.2 Japan Pertussis Vaccine Revenue by Company (2016-2021)
9.2 Japan Pertussis Vaccine Sales Breakdown by Type
9.2.1 Japan Pertussis Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Pertussis Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Pertussis Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Pertussis Vaccine Market Facts & Figures
10.1 Southeast Asia Pertussis Vaccine Sales by Company
10.1.1 Southeast Asia Pertussis Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Pertussis Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Pertussis Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Pertussis Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Pertussis Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Pertussis Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Pertussis Vaccine Market Facts & Figures
11.1 India Pertussis Vaccine Sales by Company
11.1.1 India Pertussis Vaccine Sales by Company (2016-2021)
11.1.2 India Pertussis Vaccine Revenue by Company (2016-2021)
11.2 India Pertussis Vaccine Sales Breakdown by Type
11.2.1 India Pertussis Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Pertussis Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Pertussis Vaccine Sales Breakdown by Application
11.3.1 India Pertussis Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Pertussis Vaccine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Pertussis Vaccine Business
12.1 Sanofi Pasteur
12.1.1 Sanofi Pasteur Corporation Information
12.1.2 Sanofi Pasteur Business Overview
12.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Pasteur Pertussis Vaccine Products Offered
12.1.5 Sanofi Pasteur Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Pertussis Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Mitsubishi Tanabe Pharma
12.3.1 Mitsubishi Tanabe Pharma Corporation Information
12.3.2 Mitsubishi Tanabe Pharma Business Overview
12.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered
12.3.5 Mitsubishi Tanabe Pharma Recent Development
12.4 Wuhan Institute of Biological Products
12.4.1 Wuhan Institute of Biological Products Corporation Information
12.4.2 Wuhan Institute of Biological Products Business Overview
12.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered
12.4.5 Wuhan Institute of Biological Products Recent Development
12.5 Walvax Biotechnology
12.5.1 Walvax Biotechnology Corporation Information
12.5.2 Walvax Biotechnology Business Overview
12.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Walvax Biotechnology Pertussis Vaccine Products Offered
12.5.5 Walvax Biotechnology Recent Development
12.6 Minhai Biotechnology
12.6.1 Minhai Biotechnology Corporation Information
12.6.2 Minhai Biotechnology Business Overview
12.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Minhai Biotechnology Pertussis Vaccine Products Offered
12.6.5 Minhai Biotechnology Recent Development

13 Pertussis Vaccine Manufacturing Cost Analysis
13.1 Pertussis Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pertussis Vaccine
13.4 Pertussis Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pertussis Vaccine Distributors List
14.3 Pertussis Vaccine Customers

15 Market Dynamics
15.1 Pertussis Vaccine Market Trends
15.2 Pertussis Vaccine Drivers
15.3 Pertussis Vaccine Market Challenges
15.4 Pertussis Vaccine Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の百日咳ワクチン販売市場2021(Global Pertussis Vaccine Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。